BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Net income, 2025
- $7.1B
- 10-year CAGR
- +16.2%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $7.1B | — |
| 2024 | −$8.9B | — |
| 2023 | $8.0B | +26.8% |
| 2022 | $6.3B | −9.5% |
| 2021 | $7.0B | — |
| 2020 | −$9.0B | — |
| 2019 | $3.4B | −30.1% |
| 2018 | $4.9B | +388.6% |
| 2017 | $1.0B | −77.4% |
| 2016 | $4.5B | +184.8% |
| 2015 | $1.6B | −21.9% |
| 2014 | $2.0B | −21.8% |
| 2013 | $2.6B | +30.8% |
| 2012 | $2.0B | −47.2% |
| 2011 | $3.7B | +19.6% |
| 2010 | $3.1B | −70.8% |
| 2009 | $10.6B | +102.2% |
| 2008 | $5.2B | +142.4% |
| 2007 | $2.2B | — |